AGILE THERAPEUTICS INC Quarterly Depreciation in USD from Q1 2014 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Agile Therapeutics Inc quarterly/annual Depreciation history and growth rate from Q1 2014 to Q1 2024.
  • Agile Therapeutics Inc Depreciation for the quarter ending March 31, 2024 was $26K, unchanged year-over-year.
  • Agile Therapeutics Inc annual Depreciation for 2023 was $102K, a 92% decline from 2022.
  • Agile Therapeutics Inc annual Depreciation for 2022 was $1.28M, a 38% decline from 2021.
  • Agile Therapeutics Inc annual Depreciation for 2021 was $2.06M, a 1866% increase from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $26K $0 0% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q1 2023 $26K -$501K -95.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q1 2022 $527K +$14K +2.73% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q1 2021 $513K +$509K +12725% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q1 2020 $4K -$1K -20% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q1 2019 $5K -$1K -16.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-05
Q1 2018 $6K +$1K +20% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-03
Q1 2017 $5K +$1K +25% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-07
Q1 2016 $4K -$1K -20% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q1 2015 $5K +$2.41K +93.3% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q1 2014 $2.59K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.